Kashiv BioSciences Acquired by Amneal Pharmaceuticals | Healthcare M&A Deal

Amneal Pharmaceuticals has agreed to acquire Kashiv BioSciences, a pharmacy business in the healthcare sector in the United States. Kashiv BioSciences develops and manufactures biosimilar medicines, supporting Amneal Pharmaceuticals’ strategy to expand its global biosimilar portfolio and strengthen supply capabilities. The Kashiv BioSciences acquisition supports Amneal Pharmaceuticals acquisitions focused on building an integrated biosimilar platform across development, manufacturing, and commercialization. The merger acquisition is structured as a strategic acquisition, with deal size undisclosed, and is currently announced pending customary closing conditions.